MONTREAL, QUEBEC–(Marketwired – May 10, 2017) – Emerillon Capital and Sanderling Ventures announced they are joining forces to finance PreciThera Inc, an emerging Montreal based precision medicine company dedicated to the design and the development of innovative biological agents for the treatment of orphan diseases. PreciThera was recently founded by two internationally renowned scientists and successful entrepreneurs, Drs. Philippe Crine and Susan Schiavi. This initial financing is aimed at launching the company and securing a significant Series A round with several top tier Canadian and foreign investors.
May 10, 2017 at 11:42PM
from
No comments:
Post a Comment